Sebastian Pomplun
Affiliations: | Massachusetts Institute of Technology, Cambridge, MA, United States |
Area:
Bioorganic chemistry, combinatorial drug discovery, chemical biology,Google:
"Sebastian Pomplun"Mean distance: (not calculated yet)
Parents
Sign in to add mentorFelix Hausch | grad student | MPI Psychiatry Munich | |
Brad L. Pentelute | post-doc | MIT |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ellenbroek BD, Kahler JP, Arella D, et al. (2024) Development of DuoMYC: a synthetic cell penetrant miniprotein that efficiently inhibits the oncogenic transcription factor MYC. Angewandte Chemie (International Ed. in English). e202416082 |
Charalampidou A, Nehls T, Meyners C, et al. (2024) Automated Flow Peptide Synthesis Enables Engineering of Proteins with Stabilized Transient Binding Pockets. Acs Central Science. 10: 649-657 |
Stransky F, Kostrz D, Follenfant M, et al. (2024) Use of DNA forceps to measure receptor-ligand dissociation equilibrium constants in a single-molecule competition assay. Methods in Enzymology. 694: 51-82 |
Ellenbroek BD, Kahler JP, Evers SR, et al. (2024) Synthetic Peptides: Promising Modalities for the Targeting of Disease-Related Nucleic Acids. Angewandte Chemie (International Ed. in English). e202401704 |
Kolos JM, Pomplun S, Jung S, et al. (2021) Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides. Chemical Science. 12: 14758-14765 |
Pomplun S, Jbara M, Schissel CK, et al. (2021) Parallel Automated Flow Synthesis of Covalent Protein Complexes That Can Inhibit MYC-Driven Transcription. Acs Central Science. 7: 1408-1418 |
Jbara M, Pomplun S, Schissel CK, et al. (2021) Engineering Bioactive Dimeric Transcription Factor Analogs via Palladium Rebound Reagents. Journal of the American Chemical Society |
Pomplun S, Jbara M, Quartararo AJ, et al. (2021) Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein. Acs Central Science. 7: 156-163 |
Pomplun S. (2021) Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides Rsc Medicinal Chemistry. 12: 197-202 |
Pomplun S. (2020) Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides. Rsc Medicinal Chemistry. 12: 197-202 |